Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $117,354 - $140,302
11,890 New
11,890 $125,000
Q3 2023

Nov 14, 2023

SELL
$9.76 - $13.19 $907,328 - $1.23 Million
-92,964 Reduced 94.82%
5,078 $59,000
Q2 2023

Aug 14, 2023

BUY
$7.09 - $10.08 $565,590 - $804,111
79,773 Added 436.66%
98,042 $988,000
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $50,896 - $73,402
7,355 Added 67.39%
18,269 $134,000
Q4 2022

Feb 14, 2023

BUY
$3.36 - $7.99 $36,671 - $87,202
10,914 New
10,914 $87,000
Q2 2022

Aug 15, 2022

BUY
$2.81 - $4.84 $2,804 - $4,830
998 New
998 $4,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.